» Authors » Chung-Y Hsu

Chung-Y Hsu

Explore the profile of Chung-Y Hsu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 81
Citations 611
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang H, Lin W, Shih P, Peng S, Hsu C, Lin C, et al.
Healthcare (Basel) . 2023 May; 11(10). PMID: 37239796
Patients with chronic spontaneous urticaria (CSU) have a higher risk of developing hypertension. This study aimed to determine whether acupuncture could decrease the risk of hypertension in patients with CSU....
2.
Lin J, Chen H, Lin M, Hsu C
Endocr Metab Immune Disord Drug Targets . 2023 Apr; 23(14):1762-1770. PMID: 37114787
Background: The risk factors for Systemic Autoimmune Disease (SAD)s with antiarrhythmic drugs (AAD)s in arrhythmia patients are still unclear. Aims: This study discussed these risk factors for SADs with AADs...
3.
Shih I, Hsu C, Li T, Wang S
Int J Environ Res Public Health . 2023 Feb; 20(4). PMID: 36834253
Previous studies reported an increased risk of benign paroxysmal positional vertigo (BPPV) in patients with migraine. Hence, we aimed to assess the risk of migraine in patients with BPPV. This...
4.
Wang C, Chen C, Hsieh W, Hsu T, Hsu C, Cheng Y, et al.
Int J Environ Res Public Health . 2023 Feb; 20(3). PMID: 36768020
Background: Pulmonary tuberculosis (TB), a global health problem, is typically caused by the bacterium . Herpes zoster (HZ) is caused by the reactivation of the varicella-zoster virus (VZV). The reactivation...
5.
Liao Y, Hsu R, Wang T, Wu C, Huang S, Hsu C, et al.
Cancers (Basel) . 2023 Jan; 15(1). PMID: 36612095
Ischemic cardiac or cerebrovascular disease (ICCD) survivors represent a subpopulation with a high cancer risk. Antiplatelet medications, such as aspirin, remain a fundamental therapy for the secondary prevention of ischemic...
6.
Mao J, Lai J, Fu Y, Yip H, Lai Y, Hsu C, et al.
Biomedicines . 2022 Oct; 10(10). PMID: 36289888
Aspirin and clopidogrel are commonly prescribed alone or together among the type 2 diabetes mellitus (T2DM) patients, and both agents could affect bone metabolism. This study aimed at demonstrating the...
7.
Hung I, Chung C, Hu W, Liao Y, Hsu C, Chiang J, et al.
Evid Based Complement Alternat Med . 2022 Jul; 2022:5596829. PMID: 35832512
Background: Ischemic heart disease (IHD) related to cardiovascular or cerebrovascular disease is the leading cause of mortality and an important issue of public health worldwide. The cost of long-term healthcare...
8.
Tien N, Wu T, Lin C, Wu C, Hsu C, Fang Y, et al.
Front Med (Lausanne) . 2022 Jun; 9:910623. PMID: 35770006
Patients with inflammatory bowel disease (IBD) present a higher risk of developing cardiovascular diseases (CVDs) due to chronic inflammation, which plays an essential role in atherogenesis. Hyperlipidemia is another risk...
9.
Yeh J, Kuo I, Yip H, Hsueh M, Hsu C, Kao C
Sci Rep . 2022 Jun; 12(1):9195. PMID: 35655077
This study aimed to determine the effect of colchicine use on the risk of stroke among patients with diabetes mellitus (DM). We retrospectively enrolled patients with DM between 2000 and...
10.
Wang S, Hu K, Chang W, Hsu C
Tzu Chi Med J . 2022 Apr; 34(2):232-238. PMID: 35465279
Objectives: The prevalence of end-stage renal disease (ESRD) and the number of patients undergoing dialysis in Taiwan are high. Since September 2009, the National Health Insurance has started to provide...